The allotment status of the BLS Polymers initial public offering was expected to be announced, according to the information provided. The grey market premium, or GMP, was indicating a potential listing gain of 45%.
What the GMP indicates
GMP is an unofficial market indicator that reflects sentiment before a company’s shares begin trading. In the case of BLS Polymers, the reported premium pointed to the possibility of a gain at listing. However, the indication does not confirm the final listing price or the return investors will receive.
Why the allotment matters
The allotment announcement will determine which IPO applicants receive shares. Investors awaiting the outcome can use the relevant allotment-status facility to check whether shares have been assigned to them.
What investors should note
The reported 45% figure is a GMP-based indication rather than a guaranteed outcome. The supplied information does not provide further details on the issue size, subscription figures, registrar or expected listing date.
BLS Polymers investors are therefore awaiting the formal allotment result, while the grey market signal remains an unofficial gauge of potential listing performance.